| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.39B | -1.8% |
| Cost of Revenue | $3.77B | -2.1% |
| Gross Profit | $1.63B | -1.0% |
| R&D Expense | $93.4M | -3.6% |
| SG&A Expense | $752.6M | -0.9% |
| Operating Income | $735.9M | -2.5% |
| Pre-tax Income | $458.4M | +6.7% |
| Income Tax | $188.9M | +109.0% |
| Net Income | $264.7M | -22.5% |
| EPS (Basic) | $1.82 | -23.2% |
| EPS (Diluted) | $1.81 | -23.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $371.8M | +7.4% |
| Accounts Receivable | $443.1M | +0.1% |
| Inventory | $722.2M | -6.7% |
| Current Assets | $1.89B | -3.6% |
| Total Assets | $7.02B | -2.5% |
| Current Liabilities | $1.64B | +8.4% |
| Long-term Debt | $4.30B | -6.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $728.0M | +41.0% |
| Capital Expenditures | $220.2M | -9.8% |
| Investing Cash Flow | -$232.5M | +83.1% |
| Financing Cash Flow | -$432.8M | -157.3% |
| Free Cash Flow | $507.8M | +86.7% |
| Total Liabilities |
| $6.40B |
| -3.8% |
| Stockholders' Equity | $624.5M | +13.6% |